Newsroom24x7 Network

New Delhi: The Competition Commission of India (CCI) has approved the proposed acquisition of 100% shareholding of Lanco Amarkantak Power Limited by PFC Projects Limited, REC Limited, SJVN Limited and Damodar Valley Corporation.

The proposed combination relates to acquisition of 100% shareholding of Lanco Amarkantak Power Limited (LAPL) by PFC Projects Limited (PPL), REC Limited (REC), SJVN Limited (SJVN) and Damodar Valley Corporation (DVC).

Acquirers

PPL is a wholly owned subsidiary of Power Finance Corporation Limited (PFC), a Government of India undertaking. PPL has been set up to, inter alia, carry out the business of power generation and distribution.

REC is a subsidiary of PFC. It is presently a non-banking financial company categorized as an infrastructure finance company by the Reserve Bank of India.

SJVN is a listed company held by the Government of Himachal Pradesh and public shareholders. At present, SJVN is implementing and operating projects in, inter alia, the States of Himachal Pradesh, Uttarakhand, Bihar, Maharashtra, and Uttar Pradesh in India

DVC is a statutory corporation set up under the Damodar Valley Corporation Act, 1948. It is engaged in the businesses of, inter alia, power generation, transmission, and water management in India.

Target

LAPL is an unlisted public limited company engaged in power generation in India.

CCI approves acquisition of majority stake in Indira IVF by Zonnebaars and amalgamation of Spaceway Wellness into Indira IVF

The Competition Commission of India (CCI) has also approved acquisition of majority stake in Indira IVF by Zonnebaars and amalgamation of Spaceway Wellness into Indira IVF.

The proposed combination envisages:

Acquisition of majority shareholding of Indira IVF Hospital Private Limited (Indira IVF) by Zonnebaars Netherlands B.V. (Acquirer/Zonnebaars); and amalgamation of Spaceway Wellness Private Limited (Spaceway) with and into Indira IVF.
Zonnebaars is a part of the EQT group of investment funds, which together with its subsidiaries and funds is a global investment organisation.

Indira IVF is primarily engaged in the provision of fertility and in vitro fertilisation treatment through its hospitals/centres across India.

Spaceway is one of the promoters of Indira IVF.